Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Receivables (2017 - 2025)

Selectis Health's Receivables history spans 11 years, with the latest figure at $3.1 million for Q4 2025.

  • Quarterly results put Receivables at $3.1 million for Q4 2025, down 6.29% from a year ago — trailing twelve months through Dec 2025 was $3.1 million (down 6.29% YoY), and the annual figure for FY2025 was $3.1 million, down 6.29%.
  • Receivables for Q4 2025 was $3.1 million at Selectis Health, down from $3.2 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $4.7 million in Q2 2022 to a low of $1.8 million in Q1 2024.
  • The 5-year median for Receivables is $3.1 million (2022), against an average of $3.1 million.
  • The sharpest move saw Receivables surged 133.18% in 2021, then crashed 45.19% in 2023.
  • Year by year, Receivables stood at $4.4 million in 2021, then dropped by 10.53% to $3.9 million in 2022, then fell by 25.36% to $2.9 million in 2023, then rose by 14.32% to $3.3 million in 2024, then fell by 6.29% to $3.1 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $3.1 million, $3.2 million, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.